CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Grant or award Director acquired 37,153 shares (grant or award)
- 4 Grant or award Director acquired 37,153 shares (grant or award)
- 4 Planned sale Director sold 20,000 shares at $7.85 ($157,000)
- 4 Open-market sale Chief Financial Officer & PAO sold 14,384 shares at $7.12 ($102,414)
- 4 Open-market sale PRESIDENT AND CEO sold 27,689 shares at $7.14 ($197,699)
- 4 Planned sale GENERAL COUNSEL sold 22,355 shares at an average $7.65 ($170,921)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 5,779 shares at an average $7.13 ($41,193)
- 4 Planned sale Director sold 55,453 shares at an average $8.28 ($459,086)
- 4 Planned sale Director sold 4,547 shares at an average $6.52 ($29,625)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 4,376 shares at an average $6.18 ($27,065)
- 4 Open-market sale GENERAL COUNSEL sold 5,497 shares at an average $6.19 ($34,006)
- 4 Planned sale Director sold 20,000 shares at $6.63 ($132,600)
- 4 Planned sale Director sold 20,000 shares at $6.52 ($130,400)
- 4 Planned sale Director sold 20,000 shares at $8.09 ($161,800)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 4,586 shares at an average $6.70 ($30,721)
- 4 Open-market sale GENERAL COUNSEL sold 5,765 shares at an average $6.69 ($38,576)
- 4 Open-market buy PRESIDENT AND CEO bought 14,245 shares at $6.84 ($97,436)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $6.16 ($7,293)
- 4 Grant or award Director acquired 15,216 shares (grant or award)
- 4 Grant or award Director acquired 15,216 shares (grant or award)
Page 3 of 12 · 229 filings